Alfonso Martín-Carnicero

7PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Optimized chemotherapy sequence for metastatic pancreatic ductal adenocarcinoma patients: FOLFIRINOX followed by Gemcitabine plus nab-paclitaxel.

|Feb 12, 2026
Predictive value of natural killer (NK) cells in bone marrow for relapse in diffuse large B cell lymphoma: integrating antibody-dependent cell-mediated cytotoxicity (ADCC)-based immunotherapy.

Sofía Rincón-López, Johelys Atencio-Matos, Olalla Pereda-Sainz

|Jun 27, 2024
Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes.

Francisco Corzana, Alicia Asín, Ander Eguskiza

|Mar 13, 2024
Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer.

Pablo Garrido, Adrián Casas-Benito, Ignacio M Larrayoz

|Sep 09, 2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

|Jan 08, 2023
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

Pageof 2

Frequent Collaborators

4 joint publications

Alfredo Martínez

2 joint publications

Lucía Trilla-Fuertes

2 joint publications

Margarita Majem

2 joint publications

Elisabeth Pérez-Ruiz